
TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 20
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1197
DO  - doi:10.1002/ejhf.1197
SP  - 5
EP  - 638
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - American Journal of Transplantation
VL  - 10
IS  - s4
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2010.03108.x
DO  - doi:10.1111/j.1600-6143.2010.03108.x
SP  - 213
EP  - 571
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 21
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.21.15.1253.33889
DO  - doi:10.1592/phco.21.15.1253.33889
SP  - 1253
EP  - 1323
PY  - 2001
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - International Journal of Paediatric Dentistry
JA  - Int J Paediatr Dent
VL  - 27
IS  - S2
SN  - 0960-7439
UR  - https://doi.org/10.1111/ipd.12332
DO  - doi:10.1111/ipd.12332
SP  - 36
EP  - 140
PY  - 2017
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221404
DO  - doi:10.1002/jbmr.5650221404
SP  - s102
EP  - s151
PY  - 2007
ER  - 

TY  - JOUR
TI  - TRANSPLANT 2001: The Joint American Transplant Meeting
JO  - American Journal of Transplantation
VL  - 1
IS  - S1
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2001.tb00014.x
DO  - doi:10.1111/j.1600-6143.2001.tb00014.x
SP  - 47
EP  - 476
PY  - 2001
ER  - 

TY  - JOUR
AU  - Andersen, L. S.
AU  - Grimsrud, A.
AU  - Myer, L.
AU  - Williams, D. R.
AU  - Stein, D. J.
AU  - Seedat, S.
TI  - The psychometric properties of the K10 and K6 scales in screening for mood and anxiety disorders in the South African Stress and Health study
JO  - International Journal of Methods in Psychiatric Research
JA  - Int. J. Methods Psychiatr. Res.
VL  - 20
IS  - 4
SN  - 1049-8931
UR  - https://doi.org/10.1002/mpr.351
DO  - doi:10.1002/mpr.351
SP  - 215
EP  - 223
KW  - psychometrics
KW  - epidemiology
KW  - affective disorders
KW  - screening
KW  - South Africa
PY  - 2011
AB  - Abstract Emerging research has provided support for the use of the Kessler Psychological Distress Scales in developing countries; however, this research has yet to be extended to southern Africa. This study sought to evaluate the performance of the Kessler scales in screening for depression and anxiety disorders in the South African population. The scales along with the Composite International Diagnostic Interview (CIDI) were included in the South African Stress and Health study, a nationally representative household survey. The K10/K6 demonstrated moderate discriminating ability in detecting depression and anxiety disorders in the general population; evidenced by area under the receiver operating curves of 0.73 and 0.72 respectively. However, both scales failed to meet our acceptability criteria of high sensitivity and high positive predictive value. Examinations of differences in responding by race/ethnicity revealed that the K10/K6 [Kessler Psychological Distress Scale 10-item (K10) and the abbreviated six-item (K6)] had significantly lower discriminating ability with respect to depression and anxiety disorders among the Black group (0.71) than among the combined minority race/ethnic groups of White, Colored, and Indian/Asian (0.78; p?=?0.016). The difference in time period assessed on the K10/K6 (past 30?days) versus the CIDI (past 12?months) was a notable limitation of this study. Additional validation studies using clinician diagnostic instruments are recommended. Copyright ? 2011 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting of the American Society for Bone and Mineral Research Baltimore, MD October 4â€“7, 2013
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 28
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2201
DO  - doi:10.1002/jbmr.2201
SP  - S1
EP  - S1
PY  - 2013
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Translational Science 2012 Meeting Abstracts
JO  - Clinical and Translational Science
VL  - 5
IS  - 2
SN  - 1752-8054
UR  - https://doi.org/10.1111/j.1752-8062.2012.00398.x
DO  - doi:10.1111/j.1752-8062.2012.00398.x
SP  - 141
EP  - 210
PY  - 2012
ER  - 

TY  - JOUR
TI  - Posters
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 107
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2010.00600.x
DO  - doi:10.1111/j.1742-7843.2010.00600.x
SP  - 162
EP  - 692
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14918
DO  - doi:10.1111/ajt.14918
SP  - 479
EP  - 991
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 10
IS  - s3
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2004.0902f.x
DO  - doi:10.1111/j.1469-0691.2004.0902f.x
SP  - 486
EP  - 543
PY  - 2004
ER  - 

TY  - JOUR
TI  - AUGIS abstracts 2017
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 104
IS  - S7
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.10691
DO  - doi:10.1002/bjs.10691
SP  - 5
EP  - 68
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts (151 - 254)
JO  - American Journal of Transplantation
VL  - 3
IS  - s5
SN  - 1600-6135
UR  - https://doi.org/10.1034/j.1600-6143.3.s5.15.x
DO  - doi:10.1034/j.1600-6143.3.s5.15.x
SP  - 151
EP  - 254
PY  - 2003
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 14
IS  - s7
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2008.02007.x
DO  - doi:10.1111/j.1469-0691.2008.02007.x
SP  - S121
EP  - S666
PY  - 2008
ER  - 

TY  - JOUR
TI  - Brief Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 30
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13050
DO  - doi:10.1111/tri.13050
SP  - 165
EP  - 346
PY  - 2017
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01447.x
DO  - doi:10.1111/j.1600-6143.2006.01447.x
SP  - 473
EP  - 1061
PY  - 2006
ER  - 

TY  - JOUR
TI  - International society for developmental psychobiology 51st annual meeting abstracts 2018
JO  - Developmental Psychobiology
JA  - Developmental Psychobiology
VL  - 60
IS  - S2
SN  - 0012-1630
UR  - https://doi.org/10.1002/dev.21793
DO  - doi:10.1002/dev.21793
SP  - 4
EP  - 72
PY  - 2018
ER  - 

TY  - JOUR
TI  - Clinical Pharmacology
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 115
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.12259_2
DO  - doi:10.1111/bcpt.12259_2
SP  - 54
EP  - 91
PY  - 2014
ER  - 

TY  - JOUR
AU  - Chou, Che-Yi
AU  - Chang, Chiz-Tzung
AU  - Chen, Chao-Jung
C7  - e8580
C8  - RCM-19-0172.R1
TI  - Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry
JO  - Rapid Communications in Mass Spectrometry
JA  - Rapid Commun Mass Spectrom
VL  - n/a
IS  - n/a
SN  - 0951-4198
UR  - https://doi.org/10.1002/rcm.8580
DO  - doi:10.1002/rcm.8580
SP  - e8580
AB  - Rationale Chronic pancreatitis (CP) is a pancreatic disease with poor prognosis and pancreatic cancer (PC) is one of the most lethal types of cancer that is symptomless in the early stage. Because the clinical and image findings of CP can overlap that of pancreatic cancer (PC) which leads to confusion in the diagnosis and treatment of PC, discovery/verification/validation of more accurate protein biomarkers to diagnose CP and PC is in urgent need. Methods The PubMed, Web of Science, and Google Scholar were searched using the keywords: ?biomarker?, ?marker?, ?chronic pancreatitis?, ?pancreatic cancer? or ?proteomics? for highly related researches. We focused on the articles published after the year 2005 in this review. Results We introduce the background to CP and PC and summarize the diagnosis of CP and PC, analytically validated protein biomarkers, and proteomic approaches for discovery/verification/validation. The potential use of mass spectrometry (MS) in clinical diagnosis is also discussed. Conclusions Continuously improving sensitivity of MS can provide deeper proteome for new marker discovery and high reliability for protein marker verification, validation, and clinical diagnosis. The analytically validated protein markers could be considered as targeted protein biomarkers for developing a MS platform in the clinical validation process or clinical diagnosis of CP and PC.
ER  - 
